Qianggu concentrate: unlocking bone protection power via antioxidative SIRT1/NRF2/HO-1 pathways in type 2 diabetic osteoporosis
BackgroundQianggu Concentrate (QGHJ), a traditional Chinese medicine, is extensively used to treat Type 2 Diabetic Osteoporosis (T2DOP). Despite its widespread use, research on its therapeutic mechanisms within T2DOP is notably scarce.ObjectiveTo explore QGHJ's osteoprotection in T2DOP rats and...
Saved in:
Main Authors: | Kaili Wang (Author), Xiang Dang (Author), Yanyan Wang (Author), Qing Yang (Author), Tingting Zhang (Author), Peng Yang (Author), Ling Yuan (Author), Rongming Xu (Author), Yuqi Dang (Author), Yi Nan (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2024-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Identification of kaempferol as an OSX upregulator by network pharmacology-based analysis of qianggu Capsule for osteoporosis
by: Ann Yehong Huang, et al.
Published: (2022) -
Eldecalcitol prevented OVX-induced osteoporosis through inhibiting BMSCs senescence by regulating the SIRT1-Nrf2 signal
by: Yuying Kou, et al.
Published: (2023) -
Mechanism of Action and Therapeutic Implications of Nrf2/HO-1 in Inflammatory Bowel Disease
by: Lingling Yuan, et al.
Published: (2024) -
Hypoxic-preconditioned mesenchymal stem cell-derived small extracellular vesicles inhibit neuronal death after spinal cord injury by regulating the SIRT1/Nrf2/HO-1 pathway
by: Jian Rao, et al.
Published: (2024) -
Azithromycin Mitigates Cisplatin-Induced Lung Oxidative Stress, Inflammation and Necroptosis by Upregulating SIRT1, PPARγ, and Nrf2/HO-1 Signaling
by: Emad H. M. Hassanein, et al.
Published: (2022)